NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Jonas DE, Wines RCM, DelMonte M, et al. Drug Class Review: Controller Medications for Asthma: Final Update 1 Report [Internet]. Portland (OR): Oregon Health & Science University; 2011 Apr.

  • This publication is provided for historical reference only and the information may be out of date.

This publication is provided for historical reference only and the information may be out of date.

Cover of Drug Class Review: Controller Medications for Asthma

Drug Class Review: Controller Medications for Asthma: Final Update 1 Report [Internet].

Show details

Appendix BAbbreviations

ACTH

adrenocorticotropin hormone

AD

adjustable dosing

AQLQ

Asthma Quality of Life Questionnaire

ARF

Arformoterol

BDP

beclomethasone dipropionate

BMD

bone mineral density

BUD

budesonide

CFC

chlorofluorocarbon

CI

confidence interval

CIC

ciclesonide

COPD

chronic obstructive pulmonary disease

DPI

dry powder inhaler

ED

emergency department

FD

fixed dosing

FEV1

forced expired volume in one second

FLUN

flunisolide

FP

fluticasone propionate

FM

formoterol

FVC

forced vital capacity

GINA

Global Initiative for Asthma

HFA

hydrofluoroalkane

HPA

hypothalamo-pituitary-adrenal

HR

hazard ratio

ICS

inhaled corticosteroid

IS

inhalation suspension

ITT

intent to treat

LABA

long-acting beta-agonist

LM

leukotriene modifiers

LOCF

last observation carried forward

LTRA

leukotriene receptor antagonist

LTSI

leukotriene synthesis inhibitor

MART

maintenance and reliever therapy

MDI

metered dose inhaler

MOM

mometasone

ML

montelukast

NAEPP

National Asthma Education and Prevention Program

NHLBI

National Heart, Lung and Blood Institute

NA

not applicable

NR

not reported

NS

not statistically significant

OCS

oral corticosteroids

OM

omalizumab

OR

odds ratio

PEF

peak expiratory flow

pMDI

pressurized metered dose inhaler

QOL

quality of life

RR

relative risk

SF-36

Medical Outcomes Study Short Form-36

SGRQ

St. George Respiratory Questionnaire

SM

salmeterol

SMART

Symbicort® maintenance and reliever therapy

SMD

standard mean difference (standard difference in means)

TAA

triamcinolone acetonide

WMD

weighted mean difference

Copyright © 2011 by Oregon Health & Science University.
Bookshelf ID: NBK56692

Views

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...